Checkpoint Therapeutics, Inc. (CKPT) News Headlines

▮ More

Date

Headline

11/2/2020 7:00:00 AM Samsung Biologics and Checkpoint Therapeutics Expand Manufacturing Partnership for Cosibelimab (Press Release)

9/18/2020 6:56:20 AM Pre-market Movers In Healthcare Sector: IMMP, SAVA, SNOA, CRDF, INO…

9/18/2020 2:31:45 AM CCXI To Face FDA In April, CRDF Soars On Colorectal Cancer Trial Data, VCNX In Deal With MRK

9/17/2020 6:41:55 AM Checkpoint Therapeutics Report Updated Interim Results From Phase 1 Clinical Trial Of Cosibelimab

9/14/2020 1:59:47 AM Checkpoint (CKPT) Hits Yearly High, Will The Rally Sustain?

8/18/2020 2:39:56 AM NVAX Begins Vaccine Trial In S.Africa, PSTX Slapped With Clinical Hold, UTHR To Face FDA In Apr.

7/17/2020 10:23:15 AM Stock Alert: Checkpoint Therapeutics CKPT Up 45%

11/22/2019 5:18:37 AM CKPT Prices Offering At $1.27/Shr

9/21/2019 7:03:07 AM Week Ahead In Pharma: 9 Stocks To Watch (AVXL, GMAB, ARAV…)

3/15/2019 7:38:47 AM Checkpoint Therapeutics FY Loss Attributable To Holders $36.4 Mln Or $1.27/Shr Vs Loss $22.7 Mln Or $1.00/Shr Last Year

1/15/2019 9:24:20 PM 7 Top Gainers In Healthcare Sector (KTOV, TYME, CRMD...)

11/2/2018 8:10:06 AM Checkpoint Therapeutics Q3 Loss Attributable To Holders $9.3 Mln Or $0.32/Shr Vs Loss Of $5.9 Mln Or $0.26/Shr Last Year

10/16/2018 8:05:29 AM Checkpoint Therapeutics Appoints Christian Béchon To Board Of Directors

9/25/2018 11:09:35 PM TGTX Slumps On UNITY-CLL Trial Update, CKPT On Watch, XBIO Awaits Data This Year

9/25/2018 8:05:54 AM Checkpoint Therapeutics Announces Presentation Of Updated Data From Phase 1/2 Trial Of EGFR Inhibitor CK-101

9/22/2018 4:07:24 AM Week Ahead In Pharmaceuticals: 10 Stocks To Watch (CKPT, SNDX, ADMP...)

9/13/2018 9:15:31 PM NMRD Up 60% In 2 Days, TLRY Keeps Hitting New Highs, MNLO Awaits Data In Oct.

9/6/2018 7:32:48 AM Checkpoint Therapeutics Says Encouraging Safety And Efficacy Data From Phase 1/2 Clinical Trial Of EGFR Inhibitor CK-101

8/16/2018 4:51:27 AM Have You Checked Checkpoint Therapeutics Yet?

8/13/2018 8:11:00 AM Checkpoint Therapeutics Announces Clinical Data On EGFR Inhibitor CK-101 Selected For Late-Breaking Oral Presentation